Form 4 for BLSM BlossomHill Therapeutics, Inc.
Accepted 2026-08-10 18:27:21 ET · period of report 2026-08-06 · accession 0001678152-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 18:27 | 2026-08-10 | BLSM | Keyes Jason A | CFO | P - Purchase | $16.00 | +700 | 700 | New | +$11.2K |
| D | 2026-08-10 18:27 | 2026-08-06 | BLSM | Keyes Jason A | CFO | A - Grant | $0.00 | +56.7K | 56.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-10 | P | A | 700 | $16.00 | 700 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2026-08-06 | A | A | 56,746 | $0.00 | 56,746 | D | $16.00 · — to 2036-08-05 | 56,746 Common Stock | (F1) 1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months. |